Featured Expert: Alice Pressman
This month PRECISIONheor would like to highlight the newest addition to the team, Vice President Alice Pressman.
This month PRECISIONheor would like to highlight the newest addition to the team, Vice President Alice Pressman.
There's been increasing interest in using Health Technology Assessment to guide coverage decisions and health policies. Recently, the COVID-19 experience has provided important lessons for value assessment of new interventions and its communication to stakeholders.
Real-world data are important sources within health care resource utilization (HCRU) research, but these databases often are repurposed for this use rather than custom designed. Some researchers are beginning to collect HCRU data within the context of clinical trials, with the intention to address research questions of interest, rather than relying solely on data salvaged from insurance claims or electronic health records.
Using a multi-disciplinary, mixed methods approach to evidence generation, PRECISIONheor has an established track record of quantifying the value of treatment and communicating insights capturing the perspectives of key stakeholders.
Want a glimpse at some of the insightful real-world evidence publications that PRECISIONheor experts have recently contributed to in order to help get life-saving treatments into the hands of patients that need them the most?
This month PRECISIONheor would like to highlight the work and expertise of Vice President Shannon Cope.
Recently, the National Institute for Health and Care Excellence (NICE) published a detailed strategy plan, outlining its vision during the next five years. Included in this report are new guidelines for technology evaluation, evidence standards, guidance adoption, and real-world data and research, which are applicable to all stakeholders, including the life science industry, regulators, healthcare providers, patients, and the public.
This month PRECISIONheor would like to highlight the work and expertise of Senior Director Steve Sison.
This month PRECISIONheor would like to highlight the work and expertise of Senior Principal Scientist Suepattra May-Slater.
This month PRECISIONheor would like to highlight the work and expertise of Senior Director Meena Venkatachalam.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ